                                                                                                           ORIGINAL RESEARCH ARTICLE
                                                                                                                                published: 25 2012
                                                                                                                         doi: 10.3389/fmicb.2012.00183



Genomic biochemical analysis diaminopimelate lysine biosynthesis pathway Verrucomicrobium
spinosum: identiï¬?cation partial characterization L,L-diaminopimelate aminotransferase UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-meso-
diaminopimelate ligase
Victoria R. Nachar 1 , Francisco C. Savka 1 , Sean E. McGroty 1 , Katherine  Donovan 2 , Rachel  North 2 ,
Renwick C. J. Dobson 2,3 , Larry J. Buckley 1 AndrÃ© O. Hudson 1 *
1
  Thomas H. Gosnell School Life Sciences, Rochester Institute Technology, Rochester, NY, USA
2
  Biomolecular Interaction Centre, School Biological Sciences, University Canterbury, Christchurch, New Zealand
3
  Department Biochemistry Molecular Biology, Bio21 Molecular Science Biotechnology Institute, University Melbourne, Parkville, VIC, Australia



Edited                                 Gram-negative bacterium Verrucomicrobium spinosum attracted recent
Naomi L. Ward, University                                           years following sequencing annotation genome. Comparative genomic
Wyoming, USA
                                          analysis V. spinosum using diaminopimelate/lysine metabolic genes Chlamydia tra-
Reviewed 
Uli Stingl, King Abdullah University   chomatis suggests V. spinosum employs L,L-diaminopimelate aminotransferase
Science Technology, Saudi Arabia      (DapL) pathway diaminopimelate/lysine biosynthesis. open reading frame corre-
Evelyn Toh, Indiana University            sponding putative dapL ortholog cloned recombinant enzyme Bloomington, USA
                                          shown possess L,L-diaminopimelate aminotransferase activity vitro. vivo analysis
Yufeng Wang, University Texas San Antonio, USA                          using functional complementation conï¬?rmed dapL ortholog able func-
*Correspondence:                          tionally complement E. coli mutant confers auxotrophy diaminopimelate AndrÃ© O. Hudson, Thomas H.            lysine. addition role lysine biosynthesis, intermediate diaminopimelate Gosnell School Life Sciences,          integral role peptidoglycan biosynthesis. end, UDP-N-acetylmuramoylalanyl-
Rochester Institute Technology, 85
                                          D-glutamyl-2,6-meso-diaminopimelate ligase ortholog identiï¬?ed, cloned, Lomb Memorial Drive, Rochester NY
14623-5603, USA.                          shown possess meso-diaminopimelate ligase activity vivo. L,L-diaminopimelate
e-mail: aohsbi@rit.edu                    aminotransferase pathway experimentally conï¬?rmed bacteria,                                           deemed pathogenic animals. animals, particularly humans, lack
                                          genetic machinery synthesis diaminopimelate/lysine novo, enzymes
                                          involved pathway attractive targets development antibiotics. dapL
                                          essential gene bacteria currently known. V. spinosum excellent candi-
                                          date investigate essentiality dapL, bacterium employs DapL pathway
                                          lysine cell wall biosynthesis, non-pathogenic humans, facile grow,                                           genetically manipulated.
                                          Keywords: lysine, diaminopimelate, L,L-diaminopimelate aminotransferase, peptidoglycan, functional complemen-
                                          tation


INTRODUCTION                                                                      diaminopimelate/lysine novo bacterium pro-
Verrucomicrobium spinosum rod-shaped heterotrophic Gram-                     totrophic lysine. Lysine synthesized using general
negative bacterium fresh water soil envi-                    pathways evolutionarily divergent respect ronments characterized non-motile contains                    intermediates used. pathway utilizes intermediate Î±-
appendages known prosthecae. V. spinosum important                       amino adipic acid, derived metabolism biotechnology medical sectors closely related                    2-ketoglutarate product citric acid cycle. Î±-amino Chlamydia (Wagner Horn, 2006). recent study                          adipic acid pathway primarily used fungi narrowly
ï¬?rmed organism contains genetic components                    distributed species belonging domain archaea
encode Type III Secretion able kill Drosophila                (Nishida et al., 1999; Velasco et al., 2002). pathway
melanogaster Caenorhabditis elegans, model invertebrate                   employs intermediate diaminopimelate, derived hosts (Sait et al., 2011).                                                        oxaloacetate. diaminopimelate pathway bac-
   Genomic analysis V. spinousm organ-                           teria photosynthetic organisms including cyanobacteria, algae,
ism contains genes necessary synthesis                         plants.



www.frontiersin.org                                                                                                           2012 | Volume 3 | Article 183 | 1
 Nachar et al.                                                                         Diaminopimelate lysine biosynthesis Verrucomicrobium spinosum




    variants diaminopimelate/lysine pathway                   L,L-diaminopimelate tetrahydrodipicolinate transam- discovered far (Figure 1): acyl pathways,                      ination reaction using glutamate amino donor use succinyl acetyl intermediates; meso-                   tetrahydrodipicolinate amino acceptor single reac-
diaminopimelate dehydrogenase pathway; recently dis-                   tion bypassing 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate
covered L,L-diaminopimelate aminotransferasae (DapL) pathway                   -acyl-transferase, acyl-diaminopimelate aminotransferase, acyl-
(Hudson et al., 2006, 2008; McCoy et al., 2006). biosyn-                   diaminopimelate deacylase steps present succinylated thesis lysine aspartate diaminopimelate/lysine                 acetylated diaminopimelate/lysine pathways (Table 1, Figure 1).
pathway divided main events. ï¬?rst event                  ultimate event diaminopimelate variant path- synthesis tetrahydrodipicolinate aspartate.             ways deï¬?ned enzyme meso-diaminopimelate decarboxy- general feature diaminopimelate pathway variants                 lase catalyzes decarboxylation meso-diaminopimelate carried enzymes, aspartate kinase, aspartate                 synthesize lysine. decarboxylation step shared semialdehyde dehydrogenase, dihydrodipicolinate synthase,                  variants (Table 1, Figure 1).
dihydrodipicolinate reductase, respectively (Table 1). sec-                    animals contain machinery synthesize
ond event constitutes conversion tetrahydrodipicolinate                 diaminopimelate lysine, used bacteria pep- penultimate intermediate meso-diaminopimelate. syn-                 tidoglycan biosynthesis, enzymes involved bacterial
thetic steps tetrahydrodipicolinate meso-diaminopimelate               diaminopimelate/lysine biosynthesis pathways deï¬?ne uniqueness diaminopimelate variant pathways.                  scientiï¬?c community. meso-Diaminopimelate serves acyl pathways, enzymes required. reactions               cross linking amino acids cell wall Gram- carried enzymes 2,3,4,5-tetrahydropyridine-2,6-                 negative bacteria, lysine role Gram-
dicarboxylate N -acyl-transferase, acyl-diaminopimelate amino-                 positive bacteria (Hutton et al., 2007). Inhibition enzymes
transferase, acyl-diaminopimelate deacylase, diaminopime-                  diaminopimelate/lysine biosynthesis pathways late epimerase, respectively (Table 1, Figure 1). dehy-                 detrimental effect bacterial growth perspectives:
drogenase pathway, tetrahydrodipicolinate converted meso-                diaminopimelate necessary cell wall synthesis, cell lysis
diaminopimelate enzyme meso-diaminopimelate dehydro-                    occur result osmotic pressure lack pep-
genase step circumventing 2,3,4,5-tetrahydropyridine-               tidoglycan (Cox, 1996; Baizman et al., 2000); addition, 2,6-dicarboxylate-acyl-transferase, acyl-diaminopimelate amino-                inhibition enzymes pathway prevent protein syn-
transferase, acyl-diaminopimelate deacylase, diaminopime-                  thesis, lysine 20 common proteogenic amino
late epimerase enzymatic reactions (Table 1, Figure 1). L,L-               acids. meso-Diaminopimelate incorporated cross
diaminopimelate aminotransferase (DapL) pathway synthesizes                    linking amino acids cell wall Gram-negative bacteria




  FIGURE 1 | Diaminopimelate/lysine biosynthesis pathways.            pathways, (B) meso-diaminopimelate dehydrogenase pathway, (C)   variants diaminopimelate/lysine biosynthetic pathways starting   L,L-diaminopimelate aminotransferase (DapL) pathway. abbreviations   tetrahydrodipicolinate denoted   succinylated acetylated     enzymes enzyme reaction deï¬?nitions listed Table 1.




Frontiers Microbiology | Evolutionary Genomic Microbiology                                                        2012 | Volume 3 | Article 183 | 2
 Nachar et al.                                                                                Diaminopimelate lysine biosynthesis Verrucomicrobium spinosum




Table 1 | List diaminopimelate/lysine biosynthesis genes V. spinosum DSM 4136T .

Locus tag                   Gene symbol          Gene                         EC #             Reaction definition

VspiD_010100025585          lysC                 Aspartate kinase                  2.7.2.4          ATP+aspartate â†” ADP+4-phospho-aspartate
VspiD_010100030480          asd                  Aspartate semialdehyde            1.2.1.11         aspartate 4-semialdehyde + orthophosphate + NADP+ â†” 4-
                                                 dehydrogenase                                      phospho-L-aspartate + NADPH + H+
VspiD_010100011370          dapA                 Dihydrodipicolinate               4.2.1.52         Aspartate 4-semialdehyde + pyruvate â†” L-2,3-
                                                 synthase                                           dihydrodipicolinate + 2H2 O
VspiD_010100011365          dapB                 Dihydrodipicolinate               1.3.1.26         2,3,4,5-Tetrahydrodipicolinate + NADP + â†” L-2,3-
                                                 reductase                                          dihydrodipicolinate + NADPH + H+
-                           dapD                 2,3,4,5-tetrahydropyridine-       2.3.1.117        Acyl-CoA + 2,3,4,5-tetrahydrodipicolinate + H2 O â†” CoA + N-
                                                 2,6-dicarboxylate                                  acyl-2-L-amino-6-oxoheptanedioate
                                                 Nacyl-transferase
-                           dapC                 Acyl-diaminopimelate              2.6.1.17         N-acyl-L,L-2,6-diaminoheptanedioate + 2-oxoglutarateâ†”N-
                                                 aminotransferase                                   acyl-2-L-amino-6-oxoheptanedioate + L-glutamate
-                           dapE                 Acyl-diaminopimelate              3.5.1.18         N-acyl-L,L-2,6-diaminoheptanedioate + H2 O â†” acyl + L,L-
                                                 deacylase                                          2,6-diaminoheptanedioate
-                           ddh                  Diaminopimelate                   1.4.1.16         meso-2,6-Diaminoheptanedioate + NADP+ + H2O â†” L-2-
                                                 dehydrogenase                                      amino-6-oxoheptanedioate + NH3 + NADPH
VspiD_010100012510          dapL                 L,L-diaminopimelate               2.6.1.83         L,L-2,6-diaminopimelate + 2-oxoglutarate â†” 2,3,4,5-
                                                 aminotransferase                                   tetrahydrodipicolinate + L-glutamate + H2 O
VspiD_010100011375          dapF                 Diaminopimelate                   5.1.1.7          L,L-2,6-diaminopimelateâ†”meso-2,6-diaminopimelate
                                                 epimerase
VspiD_010100003650          lysA                 Diaminopimelate                   4.1.1.20         meso-2,6-Diaminopimelateâ†’lysine + CO2
                                                 decarboxylase
 list generated using genomic information deposited IMG database (http://img.jgi.doe.gov/cgi-bin/w/main.cgi).


 enzyme UDP-N -acetylmuramoylalanyl-d-glutamyl-2,6-                          diaminopimelate/lysine biosynthesis. addition, identify meso-diaminopimelate ligase (MurE) (E.C. 6.3.2.15),                       characterize MurE V. spinosum, suggesting bacterium
encoded murE gene.                                                          incorporates meso-diaminopimelate peptidoglycan     DapL pathway identiï¬?ed numerous bacteria                       cross linking amino acid. experimentally conï¬?rmed limited number bac-
teria, deemed pathogenic (McCoy et al., 2006;                    RESULTS
Hudson et al., 2008; Liu et al., 2010). dimensional crys-                IDENTIFICATION PUTATIVE dapL murE GENES V. SPINOSUM
tal structure DapL Arabidopsis thaliana solved                    dapL ortholog V. spinosum identiï¬?ed using (Watanabe et al., 2007, 2008) Chlamydia trachomatis (Watan-                   DapL protein C. trachomatis Ct 390 (NP_219900) abe et al., 2011) algae Chlamydomonas reinhardtii                     query BlastP algorithm Integrated Microbial
(Dobson et al., 2011; Hudson et al., 2011a). Inhibitors Ara-               Genomes (IMG) database1 . search identiï¬?ed putative L,L-
bidopsis DapL ortholog reported using vitro studies                   diaminopimelate aminotransferase annotated locus tag
(Fan et al., 2010). noted inhibitors                    VspiD_010100012510 (ZP_02927470) 38  amino acid Arabidopsis DapL  known                     identity C. trachomatis DapL. murE ortholog iden-
compounds inhibit aminotransferases.                                         tiï¬?ed using C. trachomatis MurE (NP_219774) query.     identiï¬?cation dapL murE genes, addition                       search resulted identiï¬?cation murE ortholog V. easy culturability genetic manipulation V. spinosum,                    spinosum annotated locus tag VspiD_010100019130, makes bacterium excellent model organism experi-                        37  identical C. trachomatis MurE.
ments addressing essentiality dapL murE respect lysine peptidoglycan biosynthesis (Domman et al., 2011).                    CRUDE SOLUBLE PROTEIN EXTRACT V. SPINOSUM CONTAINS bacterial species contain DapL pathway difï¬?-                     DapL ACTIVITY
cult work  slow growing, difï¬?cult                 V. spinosum utilizes DapL pathway diaminopime-
culture, anaerobic, pathogenic humans.                                      late/lysine biosynthesis, suspected genomic analysis,     present ï¬?rst genomic biochemical analysis                      crude soluble protein extract possess DapL activity. diaminopimelate/lysine biosynthesis pathway V. spin-                   ortho-aminobenzaldehyde assay employed using crude sol-
osum. identify genes necessary diaminopimelate/lysine                   uble protein extract V. spinosum. Using L,L-diaminopimelate
biosynthesis genome V. spinosum demonstrate bacterium uses recently discovered DapL pathway                        1 http://www.jgi.doe.gov/




www.frontiersin.org                                                                                                            2012 | Volume 3 | Article 183 | 3
 Nachar et al.                                                                        Diaminopimelate lysine biosynthesis Verrucomicrobium spinosum



 amino donor 2-ketoglutarate amino accep-                     consistent genomic analysis regarding absence tor, assay measures production dihydroquinazolium                   diaminopimelate dehydrogenase ortholog genome V. product interaction tetrahydrodipicol-             spinosum.
inate ortho-aminobenzaldehyde. DapL activity detected crude soluble extract showing rate                    GENE ANNOTATED LOCUS TAG VspiD_010100012510
reaction proportional V. spinosum pro-                     (VsdapL) ENCODES AUTHENTIC L,L-DIAMINOPIMELATE
tein extract added assay (Figure 2). Enzymatic activity                 AMINOTRANSFERASE observed amino donor, amino accep-                         putative VsdapL gene cloned recombinant
tor, omitted assay. addition, activity                  enzyme puriï¬?ed homogeneity using afï¬?nity chromatogra-
observed protein extract heated boiling water                  phy (Figure 3). ortho-aminobenzaldehyde assay used 5 min.                                                                     determine putative VsDapL L,L-diaminopimelate
                                                                               aminotransferase activity. results analysis DapL ROUTE DIAMINOPIMELATE/LYSINE                              open reading frame annotated locus tag encodes BIOSYNTHESIS V. SPINOSUM                                                    authentic L,L-diaminopimelate aminotransferase enzyme. genome V. spinosum searched catalog genes                    L,L-diaminopimelate amino donor 2-ketoglutarate necessary novo anabolism lysine aspartate.                  amino acceptor, speciï¬?c activity VsDapL 4.1 Â± 0.25 DapL activity detected soluble extract,                    Î 440 minâˆ’1 mgâˆ’1 . Unlike plant algae enzyme, VsDapL
wanted know DapL pathway sole route                     possesses transamination activity diamine donors lysine biosynthesis. examples litera-                  structurally similar L,L-diaminopimelate, including ture multiple pathways lysine biosynthesis bacteria;                 racemic isomer meso-diaminopimelate (Table 2), albeit rela- example, genomes Bacteroides fragilis Clostridium               tively low rates. enzyme able use oxoacids
thermocellum contain DapL meso-                     amino acceptors addition 2-ketoglutarate (Table 2); diaminopimelate dehydrogenase pathways (Hudson et al., 2011b).                 relative rates low.  Corynebacterium glutamicum employs acyl pathway conjunction Ddh pathway (Schrumpf et al., 1991).                    VsdapL ABLE FUNCTIONALLY COMPLEMENT E. COLI
search V. spinosum genome suggests DapL path-                  Î”dapD/dapE (AOH1) MUTANT
way route diaminopimelate/lysine biosynthesis,                 E. coli strain AOH1 harbors deletion dapD orthologs acyl dehydrogenase genes                  gene mutation dapE renders enzyme non- identiï¬?ed genome (Table 1; Figure 1).                    functional (Hudson et al., 2006).  mutant unable search did identify diaminopimelate dehydrogenase                    synthesize meso-diaminopimelate lysine cell wall
ortholog, tested dehydrogenase activity using                  biosynthesis. result, cells lyse osmotic pressure
protein extract used detect DapL activity. test               lack meso-diaminopimelate cross linking using 1.0 mg total protein different buffer                 amino acid cell wall deemed auxotrophic systems, ï¬?nding activity. recombinant diaminopime-                      diaminopimelate lysine. complementation analysis, E.
late dehydrogenase Clostridium thermocellum used                      coli AOH1 transformed vector (pBAD33), positive control (Hudson et al., 2011b). result                  DapL expression vectors (pBAD33 + dapL)                                                                                plant Arabidopsis thaliana (AtdapL; Hudson et al., 2006),
                                                                               alga C. reinhardtii (CrdapL; Dobson et al., 2011)                                                                                bacterium V. spinosum (VsdapL). E. coli AOH1 able
                                                                               grow media supplemented L,L-diaminopimelate,
                                                                               auxotrophic mutant expressing authentic orthologous




                                                                                FIGURE 3 | Recombinant expression purification VsDapL using
 FIGURE 2 | DapL activity crude protein extract V. spinosum.          affinity chromatography. Lane (1) Protein Marker (kDa), Lane (2) 10 Î¼g  graph shows relationship protein reaction       soluble protein uninduced cells, Lane (3) 10 Î¼g soluble proteins
 rate. DapL ortho-aminobenzaldehyde assay described Section       induced cells, Lane (4) 1 Î¼g puriï¬?ed VsDapL. proteins  â€œMaterials Methods.â€? assay triplicates protein    resolved 10  (w/v) acrylamide gel stained Coomassie
 concentration.                                                                 blue visualization.




Frontiers Microbiology | Evolutionary Genomic Microbiology                                                       2012 | Volume 3 | Article 183 | 4
 Nachar et al.                                                                    Diaminopimelate lysine biosynthesis Verrucomicrobium spinosum




DapLs able grow L,L-diaminopimelate-free media                  VsmurE ABLE FUNCTIONALLY COMPLEMENT E. COLI murE
(Figure 4). analysis demonstrates recombinant               MUTANT
enzymes able convert tetrahydrodipicolinate L,L-                meso-Diaminopimelate serves penultimate pre-
diaminopimelate, bypassing acyl enzymatic reactions present         cursor lysine biosynthesis, incorporated E. coli acyl pathway, facilitate synthesis meso-         cross linking amino acids cell wall Gram-
diaminopimelate lysine cell wall biosynthesis (Figures 1          negative bacteria. facilitated enzyme UDP-N - 5).                                                                   acetylmuramoylalanyl-D-glutamyl-2,6-meso-diaminopimelate lig-
                                                                          ase (MurE; Figure 5). V. spinosum classiï¬?ed Gram-
VsDapL BELONGS DAPL1 FORM L,L-DIAMINOPIMELATE                   negative bacterium, possess MurE ortholog (Schlesner
AMINOTRANSFERASES                                                         et al., 2006). VsmurE ortholog identiï¬?ed open
Diaminopimelate aminotransferases approximately 400 amino             reading frame cloned expression vector test acids length members pyridoxal-5 phosphate             functional complementation gene encodes authen-
dependent family class II transaminases. recent study              tic MurE enzyme. E. coli mutant TKL-11 harbors muta-
revealed diverged forms DapL enzymes;               tion murE gene results temperature sensitive
DapL1 DapL2 (Hudson et al., 2008). forms                   growth phenotype mutant able grow 
DapLs share approximately 30  homology amino acid                  missive temperature 30ËšC, 42ËšC (Lugtenberg level. DapL ortholog C. trachomatis evolutionar-              van Schijndel-van Dam, 1972). mutant transformed ily related DapL1 enzymes (Hudson et al., 2008).             vector (pBAD33) vector expressing puta-
homology V. spinosum DapL 38  C. tra-               tive MurE (pBAD33 + VsmurE). Using replica-plating, results
chomatis ortholog, form V. spinosum DapL               analysis demonstrate permissive temperature
apparent. Using phylogenetic analysis, DapL ortholog             30ËšC, mutant harboring vector control vec-
V. spinosum clusters enzymes                 tor expressing recombinant enzyme able grow. 
experimentally conï¬?rmed DapL1 orthologs patho-                exposed non-permissive temperature 42ËšC, genic organisms (Hudson et al., 2008, 2011b). analysis shows          mutant expressing MurE ortholog able grow (Figure 7A). distinct clades, DapL1, DapL2. aspartate aminotrans-              result corroborated assessing bacterial growth ferase Yersinia pseudotuberculosis, classiï¬?ed          period 10 h. 30ËšC mutant harboring vector class II transaminase used outgroup (Figure 6).           murE expression vector grew expected.  analyses performed (ML, MP,  NJ)                cultures switched non-permissive temperature 42ËšC
moderate strong support DapL2 clade (57â€“100 )                  5 h 30ËšC, mutant harboring murE expres- DapL1 clade (56â€“99 ). variable maximum                   sion vector continued grow. optical density vector
likelihood bootstrap support alignment dependent alter-           culture declined attributed rapid lysis native alignments techniques (Clustal vs. MUSCLE) exhibiting              cell lack proper peptidoglycan synthesis (Figure 7B).
higher ML bootstrap values DapL1 DapL2 clades                 assessment crude soluble protein extracts com-
respectively. Muscle-aligned sequences generally exhibit higher           plementation experiment using SDS-PAGE analysis conï¬?rmed bootstrap support DapL1 DapL2 clades                    expression recombinant MurE (59 kDa) TKL-11 cells
Clustal.                                                                  harboring expression vector (pBAD33 + VsmurE) grown 



  FIGURE 4 | Functional complementation E. coli Î”dapD/dapE (AOH1) mutant. AOH1 mutant harboring plasmids pBAD33, pBAD33 + AtdapL,
  pBAD33 + CrdapL, pBAD33 +VsdapL replica-plated LB medium supplemented 0.2  (w/v) arabinose 50 Î¼g/mL
  L,L-diaminopimelate. presentation purposes colony vector recombinant plasmids represented diagram.




www.frontiersin.org                                                                                                2012 | Volume 3 | Article 183 | 5
 Nachar et al.                                                                         Diaminopimelate lysine biosynthesis Verrucomicrobium spinosum




  FIGURE 5 | Schematic representation bacterial peptidoglycan           muramoylalanine-D-glutamate ligase), MurE (UDP-N-acetylmuramoyl-
  synthesis using m-DAP cross linking amino acids.           L-alanyl-D-glutamate 2,6-meso-diaminopimelate ligase), MurF
  cytosolic, membrane, periplasmic steps shown. abbreviations   (UDP-N-acetylmuramoyl-tripeptide-D-alanyl-d-alanine ligase), Ddl
  enzymes follows: MurA (UDP-N-acetylglucosamine enolpyruvyl        (D-alanine-D-alanine ligase B), MraY (phospho-N-acetylmuramoyl-
  transferase), MurB (UDP-N-acetylenolpyruvoylglucosaminereductase), MurC      pentapeptide-transferase), MurG (pyrophosphoryl-undecaprenol-
  (UDP-N-acetylmuramate-L-alanine ligase), MurD (UDP-N-acetyl-                 N-acetylglucosamine transferase), PBPs (penicillin binding proteins).



42ËšC present extract TKL-11 harboring              (residues red bold), putative active site residues vector control (pBAD33) grown 30ËšC (Figure 7C).                        conserved DapL enzymes. addition, loop
                                                                               regions form active site cleft generally  AMINO ACIDS CONSTITUTE ACTIVE SITE                            served. particular, loops C conserved, CONSERVED VsDapL                                                            loop B shows variability. previous structural studies examine closely VsDapL variant amino acid                   (Watanabe et al., 2007, 2011; Dobson et al., 2011), known
level, aligned amino acid sequence DapL                loop B disordered role catalysis clear.
orthologs functionally structurally characterized              noting increased substrate promiscuity displayed Arabidopsis thaliana (Watanabe et al., 2007), C. reinhardtii (Dob-             VsDapL, possible loop B involved substrate
son et al., 2011), C. trachomatis (Watanabe et al., 2011;                  binding step.
Figure 8). VsDapL sequence similarity                         homology model VsDapL generated using CrDapL DapL sequences, like Ct DapL sequence,                   Swiss-Model Protein Modeling Server (Figure 9). tertiary truncated N-terminal region. longer N-terminal regions               structure DapL monomer annotated hav- eukaryotic sequences attributed subcellular localiza-            ing large small domain, includes arm
tion sequences, used  thaliana C. reinhardtii target               region (Figure 9A). aminotransferases approximately enzyme chloroplast, lysine biosynthesis known              100 kDa mass, representing homodimeric quaternary struc- occur (Mills Wilson, 1978). seen Figure 8                  ture. Assuming functional unit VsDapL enzyme 


Frontiers Microbiology | Evolutionary Genomic Microbiology                                                          2012 | Volume 3 | Article 183 | 6
 Nachar et al.                                                                        Diaminopimelate lysine biosynthesis Verrucomicrobium spinosum




 FIGURE 6 | Phylogenetic relationship DapL amino acid sequences.           Branch lengths proportional divergence; scale tree
 VsDapL ortholog annotated black circle. Minimum evolution      indicates percent divergence branch lengths. tree rooted
   topology shown maximum likelihood (ML), maximum                    single outgroup aspartate aminotransferase (AspC)  parsimony (MP), minimum evolution  , neighbor-joining (NJ)            Y. pseudotuberculosis. Figure drawing produced using FigTree (ver. 1.6.1;
 bootstrap values DapL1 DapL2 clades  left right).   Rambaut, 2009).


 dimer, required proper orientation conserved            essentiality dapL mutagenic experiments using transposon
active site residues active site, VsDapL probably              homologous recombination.  organism active sites (Figure 9B). Closer examination active site           aerobic, relatively easy culture non-pathogenic humans,
(Figure 9C) highlights residues conserved             unlike bacteria contain DapL pathway, Lep-
multiple sequence alignment (Figure 8) key loop regions               tospira interrogans, Bacteriodes fragilis, C. trachomatis (McCoy line active site. Importantly, model predicts loop          et al., 2006; Hudson et al., 2008).
B positioned entrance active site cleft, ideally placed          Recently, laboratories demonstrated orthologous interact substrates entering active site.                         dapL model plant Arabidopsis thaliana essen-
                                                                              tial growth development (Dobson et al., 2011). 
DISCUSSION                                                                    known true bacteria exclusively discovery new biosynthetic route diaminopimelate                  utilize DapL pathway diaminopimelate/lysine synthesis. lysine plants, algae, bacteria provides fresh target         known aminotransferase capable inter- discovery novel herbicides, algaecides, antibiotics.           converting tetrahydrodipicolinate L,L-diaminopimelate exists
amino acids constitute active site DapL conserved             bacteria solely contain DapL pathway.  suit- V. spinosum ortholog based protein alignment mod-               able dapL bacterial mutant auxotrophic diaminopime-
eling.  inhibitors Ct DapL DapL likely             late/lysine important step forward especially inhibit VsDapL. end, V. spinosum suitable bacterial              examples literature regarding substrate promis- development vivo assays discovery             cuity aminotransferases involved amino acid metabolism.
compounds able inhibit DapL facilitate antibiotic              instance, aspartate aminotransferase, tyrosine amino-
development.                                                                  transferase, branched-chain amino acid aminotransferase
    V. spinosum genetically altered using exogenous              shown possess overlapping activities E. coli (Gu
DNA, V. spinosum excellent candidate determining                et al., 1998). addition, recent study demonstrated 


www.frontiersin.org                                                                                                       2012 | Volume 3 | Article 183 | 7
 Nachar et al.                                                                           Diaminopimelate lysine biosynthesis Verrucomicrobium spinosum




                                                                                 supplemented diaminopimelate medium observe
                                                                                 growth phenotype. inhibitory compound speciï¬?c                                                                                  DapL, expect effect                                                                                  mutant.  compound effect                                                                                  wild-type parental strain used create dapL mutant.                                                                                  inhibition DapL prevent m-DAP production                                                                                  lead cell death caused lack proper protein cell wall
                                                                                 biosynthesis.
                                                                                    present elucidation biosynthetic pathway
                                                                                 diaminopimelate/lysine V. spinosum using genomic, bio-
                                                                                 chemical, structural approaches. enzymes involved                                                                                  bacterial diaminopimelate/lysine biosynthetic pathways pre-
                                                                                 sumed targets antibiotic development. identiï¬?cation                                                                                  characterization enzymes provides valuable information
                                                                                 pertaining experiments aiming elucidate essentiality                                                                                  genes involved bacterial diaminopimelate/lysine biosyn-
                                                                                 thesis pathways. DapL pathway sole route                                                                                  diaminopimelate/lysine V. spinosum. addition, bacterium
                                                                                 genetically modiï¬?ed, organism relatively easy cul-
                                                                                 ture non-pathogenic animals. criteria make V. spin-
                                                                                 osum excellent bacterial model elucidating essentiality
                                                                                 genes involved diaminopimelate/lysine metabolism.

                                                                                 MATERIALS METHODS
                                                                                 V. SPINOSUM GROWTH CONDITIONS
                                                                                 plasmids strains used study listed Table 3.                                                                                  V. spinosum DSM 4136T organism cultured R2A medium
                                                                                 26ËšC.

                                                                                 MULTIPLE-PROTEIN SEQUENCE ALIGNMENT, PHYLOGENETIC TREE
                                                                                 CONSTRUCTION, HOMOLOGY MODEL VsDapL
                                                                                 DapL protein sequence alignment generated using   FIGURE 7 | Functional complementation E.coli murE mutant.               ClustalW server2 . Phylogenetic trees constructed MUS-
    E. coli mutant TKL-11 harboring pBAD33 pBAD33 +VsmurE.                                                                                  CLE aligned amino acid sequences using maximum likelihood
  bacteria grown OD 0.1 600 nm serially diluted   10âˆ’1 , 10âˆ’2 , 10âˆ’3 using 0.85  (w/v) saline. bacteria             (ML), maximum parsimony (MP) minimum evolution  ,
  replica-plated LB medium supplemented 0.2  (w/v) arabinose.        neighbor-joining (NJ) techniques MEGA 5.05 (Tamura
  growth assessed 30 42ËšC 24 h. colony        et al., 2011). ML searches performed using likelihood-
  vector recombinant plasmid used create diagram.            based WAG (Whelan Goldman, 2001) model amino acid
  (B) Growth curve E. coli TKL-11 harboring vector
                                                                                 character evolution, gamma distributed rates sites,   pBAD33 (circles), pBAD33 +VsmurE (triangles). cells grown   30ËšC 5 h shifted 42ËšC additional ï¬?ve hours (shaded area).   proportion invariant sites estimated data set
  (C) SDS-PAGE analysis proteins extracted TKL-11 grown LB            (WAG + G + . NJ tree searches performed using
  supplemented 0.2  arabinose (w/v). Lane (1) protein ladder (kDa),         parsimony-based JTT model (Jones et al., 1992) gamma
  Lane (2) 10 Î¼g soluble protein extract TKL-11 harboring pBAD33         distributed rates (JTT + G). Optimal models determined
  grown 30ËšC, Lane (3) 10 Î¼g soluble protein extract harboring
  pBAD33 +VsmurE grown 42ËšC. proteins resolved 10 
                                                                                 MEGA 5.05 iteratively tests partition hierar-
  (w/v) acrylamide gel stained Coomassie blue                  chically nested models evolution obtain best ï¬?t. Node
  visualization.                                                                 strength assessed using bootstrap technique 100
                                                                                 pseudo-replicate data sets analysis type (ML, MP,                                                                                   NJ). accessions numbers following DapL proteins 
aminotransferases involved alanine biosynthesis E. coli                Arabidopsis thaliana (AEE86265), V. spinosum (ZP_02927470),
(Yoneyama et al., 2011).                                                         C. reinhardtii (XP_001693061), C. trachomatis (NP_219900),
   Aminotransferases common genome V. spinosum                     Parachlamydia UWE25 (YP_007684), Synechocystis sp. PCC 6803
given integral role multiple anabolic catabolic path-               (BAA10583), Thermosynechococcus elongatus BP1 NP_682892),
ways. compound inhibits bacterial DapL vitro,                Bacteroides fragilis NCTC 9343 (YP_212286), Clostridium
case Arabidopsis enzyme, question com-                thermocellum 27405 (YP_001039489), Methanothermobacter
pound speciï¬?c DapL vivo investigated. way answer question use vivo studies exposing putative inhibitory compound dapL mutant                    2 http://www.ebi.ac.uk/Tools/msa/clustalw2/




Frontiers Microbiology | Evolutionary Genomic Microbiology                                                              2012 | Volume 3 | Article 183 | 8
 Nachar et al.                                                                        Diaminopimelate lysine biosynthesis Verrucomicrobium spinosum




  FIGURE 8 | Protein sequence alignment DapL V. spinosum, C.          loops line active site, asterisk refers loop
  trachomatis,  thaliana, C. reinhardtii generated using ClustalW   contributing active site opposing monomer. ClustalW scores
  server (http://www.ebi.ac.uk/Tools/msa/clustalw2/). Putative active-site    relative V. spinosum sequence  vs. C. reinhardtii = 49
  residues, based structural studies ligand bound DapL   (length = 443 residues, identity); vs.  thaliana = 45 (length = 426 residues);
  Cr DapL enzymes, shown red. loop regions correspond key   vs. C. trachomatis = 39 (length = 394 residues).



thermoautotrophicus (NP_275195), Geobacter sulfurreducens                     (NP_927054), Methanosaeta thermophila PT (YP_843230),
(NP_951224), Leptospira interrogans (YP_002757), Nostoc                       Methanospirillum hungatei JF1 (YP_504354), Dehalococcoides
PCC 7120 (NP_488367), Gloeobacter violaceus PCC 7421                          CBDB1 (YP_307791), Methanococcoides burtonii DSM 6242



www.frontiersin.org                                                                                                        2012 | Volume 3 | Article 183 | 9
 Nachar et al.                                                                Diaminopimelate lysine biosynthesis Verrucomicrobium spinosum




  FIGURE 9 | VsDapL homology model generated                 N-terminal arm region compared Cr DapL DapL. (B) Assuming
  Swiss-Model Protein Modeling Server (Arnold et al., 2006) using     dimeric structure, required place conserved active site
  Cr DapL apo structure template (PDB id: 3QGU Dobson        resides (highlighted red bold Figure 8), active sites   et al., 2011; Hudson et al., 2011a, BLAST identity = 51  (207/404   dimer shown. (C) close view active site 1 showing   residues), QMEAN4 score = 0.673).   domain structure   conserved active site residues loops lining active site    monomer. Note  seen Figure 8, VsDapL truncated     Figure 8).



(YP_565702), Methanosarcina barkeri Fusaro (YP_306095),               appropriate geometry using visualization software COOT
Methanosarcina acetivorans C2A (NP_616639), Syntrophobac-             (Emsley Cowtan, 2004).
ter fumaroxidans MPOB (YP_844192), Planctomyces brasilien-
sis DSM 5305 (YP_004269630), Planctomyces limnophilus DSM             PCR AMPLIFICATION CLONING V. SPINOSUM dapL 3776 (YP_003632005), Verrucomicrobiae bacterium DG1235                murE OPEN READING FRAMES
(ZP_05058547). accession number Yersinia pseudo-          length ORFs annotated locus tags VspiD_0101000
tuberculosis IP 32953 aspartate aminotransferase (AspC)            12510 (dapL, L,L-diaminopimelate aminotransferase) (CAH20674).                                                           VspiD_010100019130 (murE, UDP-N -acetylmuramoylalanyl-d-
    homology model VsDapL protein generated using        glutamyl-2,6-meso-diaminopimelate ligase) ampliï¬?ed Swiss-Model Protein Modeling Server (Arnold et al., 2006)         PCR. ORFs ampliï¬?ed using: 12 pmol forward using CrDapL apo structure template (PDB id: 3QGU;           reverse primers, 1 mM MgSO4 , 0.5 mM Dobson et al., 2011). model examined hand clashes      deoxynucleotide triphosphates, 0.5 ng genomic DNA 1 unit




Frontiers Microbiology | Evolutionary Genomic Microbiology                                                2012 | Volume 3 | Article 183 | 10
 Nachar et al.                                                                               Diaminopimelate lysine biosynthesis Verrucomicrobium spinosum




Table 2 | Activity VsDapL various amino donors amino                     Table 3 | Plasmids strains used study.
acceptors.
                                                                                     Plasmid/strains                                 Vendor/Reference
Amino donor                  Relative         Amino acceptor        Relative
                             activity ( )                           activity ( )     pET30A                                          Novagen, USA
                                                                                     pET100D/Topo                                    Invitrogen, USA
L,L-diaminopimelate          100              2-Ketoglutarate       100              pBAD33                                          Guzman et al. (1995)
meso-Diaminopimelate         1.6 Â± 0.35       Pyruvate              8.1 Â± 0.3        pBAD33 + AtdapL                                 Hudson et al. (2006)
L-Lysine                     3.0 Â± 0.2        Oxaloacetate          7.4 Â± 0.15       pBAD33 + CrdapL                                 Dobson et al. (2011)
L-Ornithine                  5.1 Â± 0.2        Oxovalerate           7.9 Â± 0.15       pET30A +VsdapL                                  study
                                                                                     pET100D +VsmurE                                 study assay measures production dihydroquinazolium 440 nm using
                                                                                     pBAD33 +VsdapL                                  study ortho-aminobenzaldehyde assay. assays pertaining amino
                                                                                     pBAD33 +VsmurE                                  study
donor/acceptor combination triplicates, relative activity based
                                                                                     Verrucomicrobium spinosum DSM 4136              Schlesner (1987) activity enzyme L,L-diaminopimelate 2-ketoglutarate                                                                                      5-alpha competent cells                         New England Biolabs, USA
substrates.
                                                                                     BL21 codon plus RIPL                            Agilent Technologies, USA Platinum Pfx DNA polymerase (Invitrogen Corporation, Carls-                       AOH1 (Î”dapD/dapE )                              Hudson et al. (2006)
bad, CA, USA) using following PCR conditions: 1 cycle                         TKL-11 (murE )                                  Lugtenberg van
94ËšC 2 min, followed 30 cycles 94ËšC 15 s, 60ËšC                                                                     Schijndel-van Dam (1972)
30 s 72ËšC 2 min. forward reverse primers used amplify ORFs VsdapL F VsdapL R dapL ORF                         Table 4 | List Primers used PCR amplification, cloning VsmurE F VsmurE R murE ORF. nucleotide                           nucleotide sequencing.
sequences primers listed Table 4. underlined
sequence represents restriction enzyme sites used facilitate                  Primer Sequence  5 3 )
cloning ORF bolded italicized sequences repre-
                                                                                     VsdapL F         CCCCGAATTCATGGCCCTCATCAACGAAAACTTCCTCAAG
sent initiation termination codons. cloning, dapL PCR
                                                                                     VsdapL R         CCCCGTCGACCTACTTCAGCGCGGCGATACGGCGGCAGAC
fragment digested EcoRI SalI ligated                                                                                      VsmurE F         CACCATGACCATTTTGCGCGATCTTATCGAGGGT
plasmid pET30a (EMD Biosciences, Gibbstown, NJ, USA) pro-
                                                                                     VsmurE R         GTCGACTCACTGACGGTCATCCCTCCTTTGGCGTGC
duce plasmid pET30a + VsdapL. murE PCR fragment                                                                                      T7 promoter      TAATACGACTCACTATAGGG
ligated plasmid pET100D/topo (Invitrogen Corporation,
                                                                                     T7 R             TAGTTATTGCTCAGCGGTGG
Carlsbad, CA, USA) produce plasmid pE100D + VsmurE.
                                                                                     T7 terminator TATGCTAGTTATTGCTCAG recombinant protein derived plasmid carries hexa-
histidine tag derived pET30a pET100D plasmids                        underlined sequences represent restriction enzyme sites bolded ital-
amino terminus. conï¬?rm ï¬?delity PCR reactions,                      icized sequences denoted start stop codons open reading
dapL ORF sequenced pET30a using T7 promoter                             frames (ORFs). T7 terminator primer (Table 4). murE ORF sequenced pET100D using T7 promoter T7 R primer                         V. spinosum (pBAD33 + VsdapL), Arabidopsis thaliana
(Table 4). dapL murE ORFs 100  identical                     (pBAD33 + AtdapL), C. reinhardtii (pBAD33 + CrdapL).
sequences deposited Integrated Microbial Genomes (IMG)                        Transformants selected LB agar medium supplemented
public database3 .                                                                   50 Î¼g mLâˆ’1 DAP 34 Î¼g mLâˆ’1 chloramphenicol.                                                                                      individual colonies vector recombinant
FUNCTIONAL COMPLEMENTATION PLASMID CONSTRUCTS                                        plasmid replica-plated LB medium plus 0.2  plasmids used functional complementation E.                           (w/v) arabinose 50 Î¼g mLâˆ’1 DAP. cultures
coli Î”dapD/dapE double mutant E. coli murE mutant                            grown 30ËšC 24 h. E. coli murE mutant (TKL-11) produced sub-cloning XbaI SalI fragment                         (thr-1, leuB6  , murE1, fhuA21, codA1, lacY1, tsx-95, glnV44
pET30a + VsdapL pET100D + VsmurE plasmids                                , Î»âˆ’ , pyrF101, 108, thyA6, argG66, ilvA634, thi-1, deoC1)
pBAD33 produce pBAD33 + VsdapL pBAD33 + VsmurE                                transformed pBAD33 pBAD33 + VsmurE (Table 3).
(Guzman et al., 1995). fusion proteins produced                         Transformants selected LB agar medium supplemented
pBAD33 constructs identical proteins produced                        50 Î¼g mLâˆ’1 thymine 34 Î¼g mLâˆ’1 chloramphenicol pET30a pET100D constructs.                                                   30ËšC. individual colonies vector recombi-
                                                                                     nant plasmid transformation replica-plated LB medium
FUNCTIONAL COMPLEMENTATION E. COLI dapD/E murE                            plus 0.2  (w/v) arabinose 50 Î¼g mLâˆ’1 thymine. cul-
MUTANTS                                                                              tures grown 30 42ËšC 24 h assess functional E. coli mutant AOH1 (dapD::Kan2, dapE6 ) trans-                             complementation.
formed pBAD33 plasmids harboring dapL orthologs
                                                                                     PROTEIN EXPRESSION PURIFICATION VsDapL
                                                                                     E. coli BL21-CodonPlus-RIPL strain transformed 3 http://img.jgi.doe.gov/cgi-bin/w/main.cgi                                          plasmid pET30a + VsdapL grown LB broth containing



www.frontiersin.org                                                                                                            2012 | Volume 3 | Article 183 | 11
 Nachar et al.                                                                                 Diaminopimelate lysine biosynthesis Verrucomicrobium spinosum




50 Î¼g mLâˆ’1 kanamycin 34 Î¼g mLâˆ’1 chloramphenicol 37ËšC                           MESO-DIAMINOPIMELATE DEHYDROGENASE ACTIVITY OD600 0.5. Protein expression induced 1.0 L                        Ddh activity assessed using oxidative deamination. assay
culture using isopropyl Î²-d-1-thiogalactopyranoside ï¬?nal                         consisted 0.5 mM m-DAP, 0.5 mM NADP+ , 1 mg crude
concentration 0.5 mM 6 h 20ËšC. cell pellet lysed                    soluble V. spinosum extract 10 Î¼g pure recombinant meso- sonication solution 50 mM sodium phosphate (pH 8.0)                        diaminopimelate dehydrogenase C. thermocellum (Hudson 300 mM NaCl. soluble extract incubated 1 mL                          et al., 2011b) 100 mM glycine-KOH (pH 10.5) 100 mM
bed volume Talon Metal Afï¬?nity Resin (Clontech, Mountain                           HEPES-KOH (pH 7.6) ï¬?nal volume 0.5 mL. produc-
View, CA, USA) 30 min 4ËšC. resin washed ï¬?ve                            tion NADPH measured continuously 340 nm 30ËšC
times 30 mL sonication buffer containing 10 mM imi-                           using Beckman DU640 spectrophotometer
dazole (pH 8.0) 15 min  enzyme eluted 10 mL sonication buffer containing 250 mM imidazole (pH                            ACKNOWLEDGMENTS
8.0). pure protein concentrated Amicon Ultra                            research supported United States National Science
10,000 molecular weight cutoff ï¬?lter unit replacing elution                       Foundation (NSF) award AOH (MCB-1120541). Victoria R.
buffer 100 mM HEPES-KOH containing 1 mM DTT, 2 mM                                Nachar supported Undergraduate Summer Research
EDTA (pH 7.6). recombinant protein stored 50                               Fellowship College Science RIT. Victoria R. Nachar glycerol. Protein concentration measured using Brad-                          Francisco C. Savka enrolled Biology Program SEM
ford assay bovine serum albumin standard (Bradford,                       enrolled Bioinformatics Program RIT. Victoria R. Nachar,
1976).                                                                                Francisco C. Savka, Sean E. McGroty supported                                                                                       NSF award (MCB-1120541) AndrÃ© O. Hudson. Renwick C. J.
L,L-DIAMINOPIMELATE AMINOTRANSFERASE ENZYME                                           Dobson acknowledges CR Roper Bequest Fellowship sup-
ORTHO-AMINOBENZALDEHYDE ASSAY                                                         port, New Zealand Royal Society Marsden Fund (UOC1013) ortho-aminobenzaldehyde assay measured formation                           funding support material based work sup-
THDPA L,L-DAP using ortho-aminobenzaldehyde,                               ported U. S. Army Research Laboratory U. S.
forms dihydroquinazolium adduct maximum absorbance                           Army Research Ofï¬?ce contract/grant number W911NF-11- 440 nm. assay contained 100 mM HEPES-KOH (pH 7.6),                             1-0481. Katherine  Donovan Rachel  North acknowledge
0.5 mM amino donor, 2 mM amino acceptor 1.25 mM ortho-                            University Canterbury Summer Scholarship Scheme. AndrÃ©
aminobenzaldehyde 10.0 Î¼g puriï¬?ed recombinant VsDapL                           O. Hudson thanks Naomi L. Ward form University Wyoming
enzyme 0.5 mL reaction. reactions incubated                          graciously providing V. spinosum strain/genomic DNA. 30ËšC change absorbance measured continuously                           authors thank Michael  Savka (RIT) helpful discussions 440 nm using Beckman DU640 spectrophotometer.                                    revisions manuscript.

REFERENCES                                    development. PLoS 6, e20439.          novel diaminopimelate biosynthe-          Jones, D. T., Taylor,W. R., Thornton,
Arnold, K., Bordoli, L., Kopp, J.,        doi:10.1371/journal.pone.0020439          sis pathway prokaryotes iden-             J. M. (1992). rapidgeneration
   Schwede, T. (2006). SWISS-          Domman, D. B., Steven, B. T.,            tiï¬?es diverged form L,L-                mutationdatamatrices pro-
   MODEL workspace: web-based               Ward, N. L. (2011). Random trans-         diaminopimelate aminotransferase.            teinsequences. Comput. Appl. Biosci.
   environment protein structure          poson mutagenesis Verrucomi-           J. Bacteriol. 190, 3256â€“3263.                8, 275â€“282.
   homology modeling. Bioinformatics          crobium spinosum DSM 4136(T).           Hudson,  O., GirÃ³n, , Dobson,       Liu, Y., White, R. H., Whitman,
   22, 195â€“201.                               Arch. Microbiol. 193, 307â€“312.            R. C. J. (2011a). Crystallization        W. B. (2010). Methanococci use Baizman, E. R., Branstrom,  , Lon-     Emsley, P., Cowtan, K. (2004). Coot:     preliminary X-ray diffraction analy-         diaminopimelate aminotransferase
   gley, C. B., Allanson, N., Soï¬  M.        model-building tools molecular        sis L,L-diaminopimelate amino-            (DapL) pathway lysine biosyn-
   J., Gange, D., Goldman, R.             graphics. Acta Crystallogr. D Biol.       transferase (DapL) Chalmy-              thesis. J. Bacteriol. 192, 3304â€“3310.
   C. (2000). Antibacterial activity       Crystallogr. 60, 2126â€“2132.               domonas reinhardtii. Acta Crystal-        Lugtenberg, E. J. J., van Schijndel-
   synthetic analogues based        Fan, C., Clay, M. D., Dehyholos, M.          logr. Sect. F Struct. Biol. Cryst. Com-      van Dam,  (1972). Temperature-
   disaccharide structure moeno-           K., Vederas, J. C. (2010).            mun. 67, 140â€“143.                            sensitive mutants Escherichia
   mycin, inhibitor bacterial           Exploration inhibitors           Hudson,  O., Klartag, , Gilvarg,           coli K-12 low activity    transglycosylase. Microbiology 146,        diaminopimelate aminotransferase.         C., Dobson, R. C. J., Marques, F.            diaminopimelic acid adding
   3129â€“3140.                                 Bioorg. Med. Chem. 18, 2141â€“2151.         G., Leustek, T. (2011b). Dual            enzyme. J. Bacteriol. 110, 41â€“46.
Bradford, M. M. (1976). rapid        Gu, W., Song, J., Bonner, C. , Xie,        diaminopimelate biosynthesis path-        McCoy,  J, Adams, N. E., Hud-
   sensitive method quantiï¬?ca-        G., Jensen, R.  (1998). PhhC        ways Bacteroides fragilis             son,  O., Gilvarg, C., Leustek, T.,
   tion microgram quantities pro-       essential aminotransferase      Clostridium thermocellum. Bochim.            Maurelli,  T. (2006). L,L-
   tein utilizing principle pro-       aromatic amino acid metabolism         Biophys. Acta 1814, 1162â€“1168.               Diaminopimelate aminotransferase,
   tein dye binding. Anal. Biochem. 72,       Pseudomonas areuginosa. Micrbiol-       Hudson,  O., Singh, B. K., Leustek,          trans-kingdom enzyme shared
   248â€“254.                                   ogy 144, 3127â€“3134.                       T., Gilvarg, C. (2006). L,L-          Chlamydia plants syn-
Cox, R. J. (1996). DAP pathway         Guzman, L. M., Belin, D., Carson, M. J.,     diaminopimelate aminotransferase             thesis diaminopimelate/lysine.
   lysine target antimi-          Beckwith, J. (1995). Tight reg-       deï¬?nes novel variant lysine         Proc. Natl. Acad. Sci. U.S  103,
   crobial agents. Nat. Prod. Rep. 13,        ulation, modulation, high level       biosynthesis pathway plants. Plant        17909â€“17914.
   29â€“43.                                     expression vectors containing      Physiol. 140, 292â€“301.                    Mills, W. R., Wilson, K. G.
Dobson, R. C. J., GirÃ³n, ,              arabinose pBAD promoter. J. Bacte-      Hutton, C. , Perugini, M. ,            (1978). Amino acid biosynthe-
   Hudson,  O. (2011). L,L-                 riol. 177, 4121â€“4130.                     Gerrard, J.  (2007). Inhibition            sis isolated pea chloroplast:
   diaminopimelate aminotransferase        Hudson,  O., Gilvarg, C.,              lysine biosynthesis: evolving          metabolism labeled aspar-
         Chlamydomonas        rein-      Leustek, T. (2008). Biochemical       antibiotic strategy. Mol. Biosyst. 3,        tate sulfate. FEBS Lett. 92,
   hardtii: target algaecide            phylogenetic characterization        458â€“465.                                     129â€“132.




Frontiers Microbiology | Evolutionary Genomic Microbiology                                                                 2012 | Volume 3 | Article 183 | 12
 Nachar et al.                                                                                   Diaminopimelate lysine biosynthesis Verrucomicrobium spinosum




Nishida, H. M., Nishiyama, N.,                  Sahm, H. (1991). functionally            James, M. N. (2011). struc-          conducted absence com-
    Kobayashi, T., Kosuge, T., Hoshimo,         split pathway lysine synthesis         ture L,L-diaminopimelate amino-       mercial ï¬?nancial relationships     T., Yamane, H. (1999).                Corynebacterium glutamicum. J.          transferase Chlamydia tra-          construed potential 
    prokaryotic gene cluster involved           Bacteriol. 173, 4510â€“4516.                 chomatis: implications broad     ï¬‚ict 
    synthesis lysine           Tamura, K., Peterson, D., Peterson,           substrate speciï¬?city. J. Mol Biol. 19,
    amino adipate pathway:                N., Stecher, G., Nei, M.,              649â€“660.                                 Received: 14 January 2012; accepted: 02
    key evolution amino               Kumar, S. (2011). MEGA5: mole-          Watanabe, N., Clay, M. D., van Belkum,      2012; published online: 25     acid biosynthesis. Genome Res. 9,           cular evolutionary genetics analy-         M. J., Marcus, S. L., Flegel, M.         2012.
    1175â€“1183.                                  sis using maximum likelihood,              D., Clay, M. D., Deyholos, M.            Citation: Nachar VR, Savka FC,
Rambaut,  (2009). FigTree: Tree Figure        evolutionary distance, maxi-           K., Vederas, J. C., James, M.        McGroty SE, Donovan KA, North RA,
    Drawing Tool. Version 1.3.1, Insti-         mumparsimony. Mol. Biol. Evol. 28,         N. (2007). Crystal structure          Dobson RCJ, Buckley LJ Hudson
    tute Evolutionary Biology, Uni-          2731â€“2739.                                 L,L-diaminopimelate aminotrans-          AO (2012) Genomic biochemi-
    versity Edinburgh. Available       Velasco,  M., Leguina, J. , Laz-      ferase Arabidopsis thaliana:      cal analysis diaminopimelate
    http://tree.bio.ed.ac.uk/                   cano,  (2002). Molecular evolution       recently discovered enzyme        lysine biosynthesis pathway Sait, M., Kamneva, O. K., Fay, D. S.,           lysine biosynthetic pathways.       biosynthesis L-Lysine plants       Verrucomicrobium spinosum: identiï¬?-
    Kirienko, N. V., Polek, J., Shirasu-        J. Mol. Evol. 55, 445â€“459.                 Chlamydia. J. Mol. Biol. 371,        cation partial characterization     Hiza, M. M., Ward, N. L.             Wagner, M., Horn, M. (2006).              685â€“702.                                 L,L-diaminopimelate aminotransferase
    (2011). Genomic experimental            Planctomycetes, Verrucomi-          Whelan, S., Goldman, N. (2001).               UDP-N-acetylmuramoylalanyl-
    evidence suggests Verrucomi-           crobia, Chlamydiae sister              general empirical model pro-        D-glutamyl-2,6-meso-
    crobium spinosum interacts             phyla comprise superphylum               tein evolution derived multiple     diaminopimelate ligase.  Microbio.
    eukaryotes.  Microbiol. 2:211.        biotechnological medical          protein families using maximum-        3:183. doi: 10.3389/fmicb.2012.00183
    doi:10.33389/fmicb.2011.00211               relevance. Curr. Opin